Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women with Suspected Preeclampsia

Obstetrics and Gynecology

Volumn 128, Issue 2, 2016, Pages 261-269

  Zeisler, Harald ^a   Llurba, Elisa ^a   Chantraine, Frédéric ^a   Vatish, Manu ^a   Staff, Anne Cathrine ^a   Sennström, Maria ^a   Olovsson, Matts ^a   Brennecke, Shaun P ^a   Stepan, Holger ^a   Allegranza, Deirdre ^a   Dinkel, Carina ^a   Schoedl, Maria ^a   Dilba, Peter ^a   Hund, Martin ^a   Verlohren, Stefan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OBSTETRIC DELIVERY; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECONDARY ANALYSIS; BLOOD; CLINICAL TRIAL; GESTATIONAL AGE; MULTICENTER STUDY; PREDICTIVE VALUE; PREGNANCY; PREMATURITY; TIME FACTOR;

ADULT; BIOMARKERS; DELIVERY, OBSTETRIC; FEMALE; GESTATIONAL AGE; HUMANS; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREMATURE BIRTH; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84978143551     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001525     Document Type: Article

References (11)

1. Herraiz I, Simón E, Gómez-Arriaga PI, Martinez-Moratalla JM, Garcia-Burguillo A, Jiménez EA, et al. Angiogenesis-related biomarkers (sFlt-1/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration. Int J Mol Sci 2015;16:19009-26
2. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58
3. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005
4. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 2016; 374:13-22
5. Wong AE, Grobman WA. Medically indicated-iatrogenic prematurity. Clin Perinatol 2011;38:423-39
6. Hezelgrave NL, Shennan AH, David AL. Tests to predict imminent delivery in threatened preterm labour. BMJ 2015;350: h2183
7. Tripathi R, Tyagi S, Singh N, Mala YM, Singh C, Bhalla P, et al. Can preterm labour be predicted in low risk pregnancies? Role of clinical, sonographic, and biochemical markers. J Pregnancy 2014;2014:623269
8. Hund M, Allegranza D, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth 2014;14:324
9. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911-9
10. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012;206:58. e1-8
11. Dröge L, Herraìz I, Zeisler H, Schlembach D, Stepan H, Küssel L, et al. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies. Ultrasound Obstet Gynecol 2015;45: 286-93